checkAd
    Startseite > Aktien > BioCardia > Nachrichten
    BioCardia Aktie
    0,3670
     
    EUR
    +1,10 %
    +0,0040 EUR
    Letzter Kurs 20:21:35 Lang & Schwarz
    0,3640
     
    EUR
    28.011 STK
    Geldkurs 20:21:35
    0,3700
     
    EUR
    28.011 STK
    Briefkurs 20:21:35
    ISIN: US09060U5074 · WKN: A2PLXH · USA

    Neueste Nachrichten

    BioCardia Reports First Quarter 2024 Business Highlights and Financial Results
    14.05.24 · globenewswire · BioCardia
    BioCardia to Host Q1 2024 Financial Results and Corporate Update Conference Call on May 14, 2024
    09.05.24 · globenewswire · BioCardia
    BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes
    01.05.24 · globenewswire · BioCardia
    BioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In Cohort
    25.04.24 · globenewswire · BioCardia
    BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results
    27.03.24 · globenewswire · BioCardia
    BioCardia to Host 2023 Financial Results and Corporate Update Conference Call on March 27, 2024
    20.03.24 · globenewswire · BioCardia
    BioCardia and StemCardia Announce Biotherapeutic Delivery Partnership
    13.03.24 · globenewswire · BioCardia
    BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study
    12.03.24 · globenewswire · BioCardia
    BioCardia Reports Positive Interim Results from Phase III CardiAMP Cell Therapy Heart Failure Trial, with Compelling Data in Subgroup with Elevated NTproBNP Biomarker for Heart Failure
    04.03.24 · globenewswire · BioCardia
    BioCardia Announces Activation of CardiAMP Heart Failure II Phase 3 Pivotal Study Recently Approved by FDA
    08.02.24 · globenewswire · BioCardia
    BioCardia Announces Two Scientific Abstracts Have Been Accepted at the 2024 Technology and Heart Failure Therapeutics Conference
    31.01.24 · globenewswire · BioCardia
    BioCardia Biotherapeutic Delivery and Morph Access Innovations Business Development Update for Shareholders
    03.01.24 · globenewswire · BioCardia